Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial
КАРДИОЛОГИЯ УЗБЕКИСТАНА 12(3): 259-270
Article 2019 English
Authors
TA
Taku Asano
YK
Yuki Katagiri
CC
Chun Chin Chang
Abstract
1 min read
Objectives
The aims of the present study were to investigate the applicability of quantitative flow ratio (QFR) in patients with 3-vessel disease and to demonstrate the impact of functional SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score derived from QFR (fSSQFR) on clinical outcomes.
Background
The applicability of QFR in patients with 3-vessel disease and the feasibility of fSSQFR have not yet been investigated.
Methods
All lesions interrogated using instantaneous wave-free ratio and/or fractional flow reserve in the SYNTAX II trial were retrospectively screened and analyzed for QFR. The diagnostic performance of QFR was investigated using hybrid wire-derived pressure assessment (instantaneous wave-free ratio and fractional flow reserve), used in the trial as a reference. Patients with analyzable QFR in 3 vessels were stratified according to fSSQFR to evaluate its clinical prognostic value on the basis of 2-year patient-oriented composite endpoint.
Results
QFRs were analyzable in 71.0% of lesions (836 lesions). The diagnostic performance of QFR to predict binary wire-based ischemia was substantial (area under the curve 0.81, accuracy 73.8%), with a positive predictive value of 85.9%. Independent predictors of diagnostic discordance were lesions in side branches, involvement of bifurcation or trifurcation, and small vessel. According to the 2-year patient-oriented composite endpoint, fSSQFR reclassified 26.1% of the patients (36 of 138) in the high- to intermediate-risk group into the low-risk group appropriately (net reclassification improvement 0.32; p < 0.001). The area under the curve for fSSQFR to predict the 2-year patient-oriented composite endpoint was higher than that of the classic anatomic SYNTAX score (0.68 vs. 0.56; p = 0.002).
Conclusions
QFR demonstrated substantial applicability in patients with 3-vessel disease. The fSSQFR has the potential to further refine prognostic risk estimation compared with the classic anatomic SYNTAX score.
Carlos Collet, Yosuke Miyazaki, Nicola Ryan, Taku Asano, Erhan Tenekecioğlu, Jeroen Sonck, Daniele Andreini, Manel Sabaté, Salvatore Brugaletta, Rod Stables, Antonio L. Bartorelli, Robbert J. de Winter, Yuki Katagiri, Ply Chichareon, Giovanni Luigi De Maria, Pannipa Suwannasom, Rafael Cavalcante, Hans Jonker, Marie-angèle Morel, Bernard Cosyns, A. Pieter Kappetein, David Taggart, Vasim Farooq, Javier Escaned, Adrian Banning, Yoshinobu Onuma, Patrick W. Serruys
Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Chun Chin Chang, Hidenori Komiyama, Yuki Katagiri, Taku Asano, Rod Stables, Farzin Fath‐Ordoubadi, Simon Walsh, Manel Sabaté, Justin E. Davies, Jan J. Piek, Robert‐Jan van Geuns, Johan H. C. Reiber, Adrian Banning, Javier Escaned, Vasim Farooq, Patrick W. Serruys, Yoshinobu Onuma
Hideyuki Kawashima, Norihiro Kogame, Masafumi Ono, Hironori Hara, Kuniaki Takahashi, Johan H. C. Reiber, Brian Thomsen, Robbert J. de Winter, Kaoru Tanaka, Mark La Meir, Johan De Mey, Ulrich Schneider, Torsten Doenst, Ulf Teichgräber, William Wijns, Saima Mushtaq, Giulio Pompilio, Antonio L. Bartorelli, Daniele Andreini, Patrick W. Serruys,
Discussion(0)
No comments yet. Be the first to comment.